• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆纤连蛋白的功能分析:特别考虑结合干扰因素

Functional analysis of plasma fibronectin with special consideration of binding interferences.

作者信息

Köttgen E, Hoeft S, Müller C, Hell B

出版信息

J Clin Chem Clin Biochem. 1986 Aug;24(8):541-9. doi: 10.1515/cclm.1986.24.8.541.

DOI:10.1515/cclm.1986.24.8.541
PMID:3760786
Abstract

So far, soluble fibronectin has been quantitated mostly by immunological techniques. In this investigation we show that an immunological assay provides reliable results only with intact fibronectin. Fibronectin fragments resulting from proteolysis give rise to falsely raised values. We present four functional tests based on the sandwich (ELISA) technique on microtitre plates. These quantify fibronectin on the basis of its binding capacity to collagen, heparin, fibrin and carboxy-group-modified IgG with high sensitivity, specificity and precision. Analysis of the bioactivity spectrum of intact fibronectin is not disturbed by fibronectin fragments. Furthermore we demonstrate interferences, in particular between heparin and collagen in their mutual binding to fibronectin. This provides new indications of a "substrate activation" of fibronectin.

摘要

到目前为止,可溶性纤连蛋白大多通过免疫技术进行定量。在本研究中,我们表明免疫测定仅对完整的纤连蛋白提供可靠结果。蛋白水解产生的纤连蛋白片段会导致值假性升高。我们在微量滴定板上基于夹心(ELISA)技术提出了四种功能测试。这些测试基于纤连蛋白与胶原蛋白、肝素、纤维蛋白和羧基修饰的IgG的结合能力,以高灵敏度、特异性和精密度对纤连蛋白进行定量。完整纤连蛋白的生物活性谱分析不受纤连蛋白片段的干扰。此外,我们证明了干扰,特别是肝素和胶原蛋白在它们与纤连蛋白相互结合方面的干扰。这为纤连蛋白的“底物激活”提供了新的迹象。

相似文献

1
Functional analysis of plasma fibronectin with special consideration of binding interferences.血浆纤连蛋白的功能分析:特别考虑结合干扰因素
J Clin Chem Clin Biochem. 1986 Aug;24(8):541-9. doi: 10.1515/cclm.1986.24.8.541.
2
Identification of fibronectin fragments that bind to carboxy-group-modified proteins.鉴定与羧基修饰蛋白结合的纤连蛋白片段。
Biochem J. 1983 Dec 1;215(3):613-6. doi: 10.1042/bj2150613.
3
The immunoreactivity, ligand, and cell binding characteristics of rheumatoid synovial fluid fibronectin.类风湿性滑液纤连蛋白的免疫反应性、配体及细胞结合特性
Arthritis Rheum. 1985 Jun;28(6):601-12. doi: 10.1002/art.1780280602.
4
Serologic study of immunoglobulin A-fibronectin aggregates in immunoglobulin A nephropathy.免疫球蛋白A肾病中免疫球蛋白A-纤连蛋白聚集体的血清学研究。
Am J Kidney Dis. 1996 May;27(5):622-30. doi: 10.1016/s0272-6386(96)90095-5.
5
Purification of Human Plasma/Cellular Fibronectin and Fibronectin Fragments.人血浆/细胞纤连蛋白及纤连蛋白片段的纯化
Methods Mol Biol. 2017;1627:309-324. doi: 10.1007/978-1-4939-7113-8_20.
6
Characterization of fibronectin metabolites in normal rat urine.
Biochim Biophys Acta. 1988 Nov 17;967(2):176-82. doi: 10.1016/0304-4165(88)90007-4.
7
Characterization of fibrin(ogen) fragments in gingival crevicular fluid.龈沟液中纤维蛋白(原)片段的特征分析
Scand J Dent Res. 1991 Feb;99(1):40-3. doi: 10.1111/j.1600-0722.1991.tb01020.x.
8
Affinity of myeloma IgG proteins for fibronectin.骨髓瘤IgG蛋白与纤连蛋白的亲和力。
Clin Exp Immunol. 1983 Jul;53(1):233-8.
9
Evidence for the presence of a free N-terminal fibronectin 30-kDa domain in human plasma by quantitative determination with an indirect immunosorbent assay.
Anal Biochem. 1988 Sep;173(2):228-34. doi: 10.1016/0003-2697(88)90183-2.
10
An enzyme-linked immunoassay for direct measurement of the gelatin-binding capacity of human plasma fibronectin.一种用于直接测定人血浆纤连蛋白明胶结合能力的酶联免疫测定法。
J Immunol Methods. 1986 Jul 24;91(2):205-11. doi: 10.1016/0022-1759(86)90480-1.

引用本文的文献

1
Plasma proteins in children with trichuris dysentery syndrome.鞭虫痢疾综合征患儿的血浆蛋白
J Clin Pathol. 1997 Mar;50(3):236-40. doi: 10.1136/jcp.50.3.236.
2
Proteases and antiproteases related to the coagulation system in plasma and ascites--an approach to differentiate between malignant and cirrhotic ascites.血浆和腹水中与凝血系统相关的蛋白酶和抗蛋白酶——一种区分恶性腹水和肝硬化腹水的方法
Klin Wochenschr. 1987 Jul 15;65(14):634-8. doi: 10.1007/BF01875497.